| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |